Cyclosporine Eye Drops for Contact Lens Discomfort
What You Need to Know Before You Apply
What is the purpose of this trial?
Of the 140 million contact lens (CL) wearers worldwide, most wear soft contact lenses. Despite major improvements in contact lens care, nearly 20% of wearers stop using lenses, with contact lens discomfort (CLD) being the main reason. This study aims to determine whether VEVYE, a water-free 0.1% cyclosporine ophthalmic solution indicated for the treatment of DED, can improve contact lens comfort in people with dry eye disease.
Are You a Good Fit for This Trial?
This trial is for people who wear contact lenses and experience discomfort or symptoms of dry eye. Participants should not have other serious eye conditions or allergies to the study medication.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cyclosporine 0.1% Ophthalmic Solution
Trial Overview
The study tests whether a cyclosporine 0.1% eye drop (VEVYE) can help reduce discomfort in contact lens users with dry eyes. All participants will use this medicated eye drop as part of the research.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will be treated with VEVYE (water-free cyclosporine 0.1% ophthalmic solution) twice per day in each eye before and after contact lens use.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ocular Aesthetics, LLC dba Ocular Clinical Trials
Lead Sponsor
Harrow Eye, LLC
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.